214 related articles for article (PubMed ID: 8500874)
1. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.
Loosmore S; Zealey G; Cockle S; Boux H; Chong P; Yacoob R; Klein M
Infect Immun; 1993 Jun; 61(6):2316-24. PubMed ID: 8500874
[TBL] [Abstract][Full Text] [Related]
2. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.
Buasri W; Impoolsup A; Boonchird C; Luengchaichawange A; Prompiboon P; Petre J; Panbangred W
BMC Microbiol; 2012 Apr; 12():61. PubMed ID: 22524455
[TBL] [Abstract][Full Text] [Related]
3. Development of safer pertussis DNA vaccine expressing non-toxic C180 polypeptide of pertussis toxin S1 subunit.
Kamachi K; Arakawa Y
Vaccine; 2007 Jan; 25(6):1000-6. PubMed ID: 17050047
[TBL] [Abstract][Full Text] [Related]
4. Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides.
Chong P; Zobrist G; Sia C; Loosmore S; Klein M
Infect Immun; 1992 Nov; 60(11):4640-7. PubMed ID: 1383153
[TBL] [Abstract][Full Text] [Related]
5. Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.
Loosmore SM; Zealey GR; Boux HA; Cockle SA; Radika K; Fahim RE; Zobrist GJ; Yacoob RK; Chong PC; Yao FL
Infect Immun; 1990 Nov; 58(11):3653-62. PubMed ID: 2228237
[TBL] [Abstract][Full Text] [Related]
6. Characterization of mutant strains producing pertussis toxin cross reacting materials.
Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
[TBL] [Abstract][Full Text] [Related]
7. Relationship between structure and biological and protective activities of pertussis toxin.
Sato H; Sato Y
Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
[TBL] [Abstract][Full Text] [Related]
8. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
9. Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.
Lobet Y; Feron C; Dequesne G; Simoen E; Hauser P; Locht C
J Exp Med; 1993 Jan; 177(1):79-87. PubMed ID: 8418210
[TBL] [Abstract][Full Text] [Related]
10. Protective activities in mice of monoclonal antibodies against pertussis toxin.
Sato H; Sato Y
Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
[TBL] [Abstract][Full Text] [Related]
11. The subunit S1 is important for pertussis toxin secretion.
Pizza M; Bugnoli M; Manetti R; Covacci A; Rappuoli R
J Biol Chem; 1990 Oct; 265(29):17759-63. PubMed ID: 2211659
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of Pertussis toxin subunits.
Sheu GC; Wo YY; Lu CH
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):182-93. PubMed ID: 10592823
[TBL] [Abstract][Full Text] [Related]
13. Purification and immunological characterization of HPLC-purified pertussis toxin subunits.
Chong P; Cockle S; Boux H; Klein M
Biochem Cell Biol; 1991; 69(5-6):336-40. PubMed ID: 1654940
[TBL] [Abstract][Full Text] [Related]
14. Effect of monoclonal antibody to pertussis toxin on toxin activity.
Sato H; Sato Y; Ito A; Ohishi I
Infect Immun; 1987 Apr; 55(4):909-15. PubMed ID: 2435660
[TBL] [Abstract][Full Text] [Related]
15. Identification of human T-cell epitopes on the S4 subunit of pertussis toxin.
Petersen JW; Holm A; Ibsen PH; Hasløv K; Capiau C; Heron I
Infect Immun; 1992 Oct; 60(10):3962-70. PubMed ID: 1383145
[TBL] [Abstract][Full Text] [Related]
16. Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.
Nencioni L; Pizza M; Bugnoli M; De Magistris T; Di Tommaso A; Giovannoni F; Manetti R; Marsili I; Matteucci G; Nucci D
Infect Immun; 1990 May; 58(5):1308-15. PubMed ID: 2323818
[TBL] [Abstract][Full Text] [Related]
17. Engineering of an Iranian
Nikbin VS; Keramati M; Noofeli M; Tayebzadeh F; Kahali B; Shahcheraghi F
J Med Microbiol; 2020 Jan; 69(1):111-119. PubMed ID: 31778110
[No Abstract] [Full Text] [Related]
18. Characterization of murine monoclonal antibodies that recognize defined epitopes of pertussis toxin and neutralize its toxic effect on Chinese hamster ovary cells.
Walker MJ; Wehland J; Timmis KN; Raupach B; Schmidt MA
Infect Immun; 1991 Nov; 59(11):4249-51. PubMed ID: 1718872
[TBL] [Abstract][Full Text] [Related]
19. Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages.
van't Wout J; Burnette WN; Mar VL; Rozdzinski E; Wright SD; Tuomanen EI
Infect Immun; 1992 Aug; 60(8):3303-8. PubMed ID: 1353482
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer.
Ben-Nun A; Mendel I; Kerlero de Rosbo N
Proc Assoc Am Physicians; 1997 Mar; 109(2):120-5. PubMed ID: 9069580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
